PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
13.37%
Cash & equivalents yoy growth 10-20% – strong liquidity improvement. Benjamin Graham might question if returns on this buildup are adequate. Examine short-term yields or reinvestment opportunities.
No Data
No Data available this quarter, please select a different quarter.
13.37%
Cash + STI yoy growth 10-20% – solid buildup of liquid resources. Benjamin Graham might ask if these funds are earning a reasonable return.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
12.78%
Growth 10-20% – strong increase in liquidity. Benjamin Graham would question if it's too reliant on credit or genuinely boosting solvency.
-7.38%
Declining PP&E may indicate underinvestment or asset sales. Seth Klarman would question future capacity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.96%
Declining non-current assets may signal asset sales or underinvestment. Howard Marks would investigate future growth implications.
No Data
No Data available this quarter, please select a different quarter.
12.46%
10-20% yoy – strong asset growth. Warren Buffett wants to see if these assets produce good ROA.
-8.08%
Declining payables indicates faster supplier payments but reduces free financing. Howard Marks would verify liquidity remains adequate.
2.29%
Up to 5% yoy – small increase. Howard Marks questions if operating cash flow adequately covers the new short-term debt.
No Data
No Data available this quarter, please select a different quarter.
8.08%
Growth 5-10% – moderate improvement. Seth Klarman sees decent forward demand.
-2.29%
Declining other current liabilities reduces near-term obligations. Benjamin Graham would see this as improving short-term financial position.
-6.99%
Declining current liabilities reduces short-term financial pressure. Seth Klarman would see this as improving liquidity position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-58.38%
Declining total non-current liabilities reduces long-term leverage risk. Benjamin Graham would see this as strengthening the balance sheet.
No Data
No Data available this quarter, please select a different quarter.
-9.31%
Declining total liabilities strengthens the balance sheet. Howard Marks would see this as reducing financial risk.
10.53%
Above 5% yoy – more significant share issuance. Philip Fisher demands a strong ROI or else it's dilution.
-2.12%
Declining retained earnings signals net losses or large dividends. Seth Klarman would investigate the sustainability of dividend policy.
-7.96%
Declining AOCI may indicate reduced unrealized gains or currency losses. Howard Marks would see this as potentially reducing volatility.
No Data
No Data available this quarter, please select a different quarter.
13.80%
Equity growth ≥ 10% yoy – a strengthening net worth. Warren Buffett checks if the ROE is healthy.
12.46%
≥ 12% yoy – significant balance sheet expansion. Benjamin Graham checks if the new capital is productive.
No Data
No Data available this quarter, please select a different quarter.
-16.56%
Declining total debt reduces leverage risk. Seth Klarman would see this as improving financial stability and flexibility.
-13.63%
Declining net debt indicates improving liquidity or deleveraging. Howard Marks would see this as strengthening financial position.